Previous Page  2 / 7 Next Page
Information
Show Menu
Previous Page 2 / 7 Next Page
Page Background

Page 62

Notes:

conferenceseries

.com

November 28-29, 2016 Valencia, Spain

4

th

World Congress on

Infection Prevention and Control

Volume 4, Issue 8 (Suppl)

J Infect Dis Ther 2016

ISSN: 2332-0877, JIDT an open access journal

Infection Control 2016

November 28-29, 2016

Benjamin Kung, J Infect Dis Ther 2016, 4:8 (Suppl)

http://dx.doi.org/10.4172/2332-0877.C1.021

Medical device reprocessing (MDR) in Alberta medical clinics: Patient safety risk warrants regulatory

oversight

Benjamin Kung

College of Physicians and Surgeons of Alberta, Canada

H

istorically in Alberta, responsibility for monitoring infection prevention & control (IPAC) in non-governmental, unaccredited

medical clinics had fallen on the business owner and/or physicians. In 2007, a sentinel event triggered a government directed

review of IPAC in these settings. A program was created under the direction of a 10-member Advisory Committee: Infectious disease

specialists, medical officers of health, senior infection control practitioners, and community physicians and surgeons. CPSA has

since actively monitored IPAC with a priority on standards for MDR (cleaning, disinfection and sterilization of medical devices).

Alberta has approximately 1700 medical facilities in the “non-governmental, unaccredited” category. Over 600 (>35%) perform some

type of MDR and these were assessed for adherence to standards during 2008-2015. In 2013, a provincial policy for reporting the

most critical deficiencies was formalized. From 2013-15, 131 assessments identified 17 (13.0%) with risks exceeding the reporting

threshold to public health. Deficiencies contributing to the likelihood of reporting included but were not limited to inadequate

device cleaning, lack of monitoring sterilization cycles for physical (time, temperature), chemical and/or biological parameters, use of

unlicensed sterilizers and inadequate level of reprocessing given device risk classification (Spaulding’s). Post-exposure risk assessment

deemed four (3.0%, n=131) a sufficient threat to initiate look backs for blood-borne pathogen exposure (HIV, HBV & HCV). Formal

reporting and post-exposure risk assessment confirmed initial observations suggesting clinics performing MDR are at elevated risk of

breaching IPAC principles that may jeopardize patient safety. The logistics and value of providing clinic support via robust regulatory

controls is worth exploring.

Biography

Benjamin Kung is the Program Manager of IPAC for the CPSA and additionally serves as Governance Committee Chair on the Board of Directors, Alberta Public

Health Association. He has completed his undergraduate training in Microbiology/Biology from University of Victoria and Environmental Public Health from British

Columbia Institute of Technology, followed by graduate studies in IPAC from University of British Columbia and Epidemiology at London School of Hygiene &

Tropical Medicine.

benjamin.kung@cpsa.ab.ca